In case P9, T1 harboured KRAS p. G12 V, TP53 p. H193Y and A1CF-RET fusion mutations, whereas T2 had a KRAS p. G12C mutation, suggesting that these tumours may be driven by different molecular events (Figure 3B). Here, KRAS is linked to neoplasm.